MedDataX Logo

Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients

NCT ID: NCT02755961

Last Updated: 2016-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hyperphosphatemia is an independent risk factor for mortality among dialysis patients. And most phosphate in human is derived from the food. The purpose of this study is to evaluate the efficacy of nutritional consultation and education on phosphate binder among dialysis patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hyperphosphatemia is an independent risk factor for mortality among dialysis patients. Hyperphosphatemia is associated with increased incidence of cardiovascular diseases, and is a mediator to the development of hyperparathyroidism and mineral bone disorder. Phosphate is usually obtained by food intake, and it can be removed by hemodialysis. However, the efficacy of removal is limited, so that dietary education and proper intake of phosphate binder is essential.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperphosphatemia End-stage Renal Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

End-stage renal disease Phosphate binders Hyperphosphatemia Dietary education

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

No intervention was performed

Group Type NO_INTERVENTION

No interventions assigned to this group

Education group

Dietary education and education on phosphate binder use. Pharmacists instructed patients about how to take phosphate binders properly. Dietitians educated on dietary phosphate restriction.

Group Type EXPERIMENTAL

Dietary education

Intervention Type BEHAVIORAL

Education on phosphate binder use

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary education

Intervention Type BEHAVIORAL

Education on phosphate binder use

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* End-stage renal disease patients whose dialysis vintage is more than 3 months

Exclusion Criteria

* Patients with liver cirrhosis
* Pregnant patients
* Patients with alimentary tract malabsorption diseases
* History of recent alcohol or drug abuse
* Patients receiving chemotherapy for solid organ tumor
* History of mental illness (major depressive disorder, bipolar disorder, schizophrenia, etc.)
* Patients having difficulty communicating with our medical team (dementia, mental retardation, etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ajou University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jong Cheol Jeong

Clinical Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jong Cheol Jeong, MD

Role: PRINCIPAL_INVESTIGATOR

Clinical Assistant Professor

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MED-SUR-15-147

Identifier Type: -

Identifier Source: org_study_id